Avricore Health Inc.
Avricore Health Inc. (AVCRF) Stock Competitors & Peer Comparison
See (AVCRF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AVCRF | $0.07 | +0.08% | 5.9M | -5.79 | -$0.01 | N/A |
| GNTLF | $1.00 | +0.00% | 3.7T | -16.67 | -$0.06 | N/A |
| LZAGY | $67.43 | -1.37% | 47.4B | 52.31 | $1.29 | +0.63% |
| LZAGF | $690.00 | +0.00% | 45.9B | 52.08 | $12.92 | +0.71% |
| WUXAY | $13.32 | +5.71% | 35.5B | 18.79 | $0.67 | +2.53% |
| WUXIF | $7.34 | +0.00% | 20.2B | 13.59 | $0.54 | +2.50% |
| BMXMF | $144.20 | +0.00% | 17.6B | 35.43 | $4.21 | +0.66% |
| ERFSF | $76.70 | +0.66% | 13.7B | 29.28 | $2.63 | +0.87% |
| SKHCF | $18.39 | +0.00% | 9.3B | 25.38 | $0.74 | +3.74% |
| SKHHY | $18.28 | +1.11% | 8.9B | 24.79 | $0.73 | +3.73% |
Stock Comparison
AVCRF vs GNTLF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, GNTLF has a market cap of 3.7T. Regarding current trading prices, AVCRF is priced at $0.07, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, AVCRF's ROE is -0.42%, compared to GNTLF's ROE of -3.06%. Regarding short-term risk, AVCRF is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check GNTLF's competition here
AVCRF vs LZAGY Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, LZAGY has a market cap of 47.4B. Regarding current trading prices, AVCRF is priced at $0.07, while LZAGY trades at $67.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas LZAGY's P/E ratio is 52.31. In terms of profitability, AVCRF's ROE is -0.42%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, AVCRF is more volatile compared to LZAGY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check LZAGY's competition here
AVCRF vs LZAGF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, LZAGF has a market cap of 45.9B. Regarding current trading prices, AVCRF is priced at $0.07, while LZAGF trades at $690.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas LZAGF's P/E ratio is 52.08. In terms of profitability, AVCRF's ROE is -0.42%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, AVCRF is more volatile compared to LZAGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check LZAGF's competition here
AVCRF vs WUXAY Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, WUXAY has a market cap of 35.5B. Regarding current trading prices, AVCRF is priced at $0.07, while WUXAY trades at $13.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas WUXAY's P/E ratio is 18.79. In terms of profitability, AVCRF's ROE is -0.42%, compared to WUXAY's ROE of +0.23%. Regarding short-term risk, AVCRF is more volatile compared to WUXAY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check WUXAY's competition here
AVCRF vs WUXIF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, WUXIF has a market cap of 20.2B. Regarding current trading prices, AVCRF is priced at $0.07, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, AVCRF's ROE is -0.42%, compared to WUXIF's ROE of +0.23%. Regarding short-term risk, AVCRF is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check WUXIF's competition here
AVCRF vs BMXMF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, BMXMF has a market cap of 17.6B. Regarding current trading prices, AVCRF is priced at $0.07, while BMXMF trades at $144.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas BMXMF's P/E ratio is 35.43. In terms of profitability, AVCRF's ROE is -0.42%, compared to BMXMF's ROE of +0.11%. Regarding short-term risk, AVCRF is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check BMXMF's competition here
AVCRF vs ERFSF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, ERFSF has a market cap of 13.7B. Regarding current trading prices, AVCRF is priced at $0.07, while ERFSF trades at $76.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas ERFSF's P/E ratio is 29.28. In terms of profitability, AVCRF's ROE is -0.42%, compared to ERFSF's ROE of +0.08%. Regarding short-term risk, AVCRF is more volatile compared to ERFSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check ERFSF's competition here
AVCRF vs SKHCF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, SKHCF has a market cap of 9.3B. Regarding current trading prices, AVCRF is priced at $0.07, while SKHCF trades at $18.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas SKHCF's P/E ratio is 25.38. In terms of profitability, AVCRF's ROE is -0.42%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, AVCRF is more volatile compared to SKHCF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check SKHCF's competition here
AVCRF vs SKHHY Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, SKHHY has a market cap of 8.9B. Regarding current trading prices, AVCRF is priced at $0.07, while SKHHY trades at $18.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas SKHHY's P/E ratio is 24.79. In terms of profitability, AVCRF's ROE is -0.42%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, AVCRF is more volatile compared to SKHHY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check SKHHY's competition here
AVCRF vs HNGZY Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, HNGZY has a market cap of 7.1B. Regarding current trading prices, AVCRF is priced at $0.07, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, AVCRF's ROE is -0.42%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, AVCRF is more volatile compared to HNGZY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check HNGZY's competition here
AVCRF vs DSRLF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, DSRLF has a market cap of 5.8B. Regarding current trading prices, AVCRF is priced at $0.07, while DSRLF trades at $107.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas DSRLF's P/E ratio is 26.79. In terms of profitability, AVCRF's ROE is -0.42%, compared to DSRLF's ROE of +0.12%. Regarding short-term risk, AVCRF is more volatile compared to DSRLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check DSRLF's competition here
AVCRF vs VIMGF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, VIMGF has a market cap of 2.3B. Regarding current trading prices, AVCRF is priced at $0.07, while VIMGF trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas VIMGF's P/E ratio is 86.00. In terms of profitability, AVCRF's ROE is -0.42%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, AVCRF is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check VIMGF's competition here
AVCRF vs MRCHF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, MRCHF has a market cap of 1.3B. Regarding current trading prices, AVCRF is priced at $0.07, while MRCHF trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas MRCHF's P/E ratio is 71.21. In terms of profitability, AVCRF's ROE is -0.42%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, AVCRF is more volatile compared to MRCHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check MRCHF's competition here
AVCRF vs IDGXF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, IDGXF has a market cap of 186M. Regarding current trading prices, AVCRF is priced at $0.07, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, AVCRF's ROE is -0.42%, compared to IDGXF's ROE of +0.19%. Regarding short-term risk, AVCRF is more volatile compared to IDGXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check IDGXF's competition here
AVCRF vs CORBF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, CORBF has a market cap of 180.8M. Regarding current trading prices, AVCRF is priced at $0.07, while CORBF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas CORBF's P/E ratio is 3.00. In terms of profitability, AVCRF's ROE is -0.42%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, AVCRF is less volatile compared to CORBF. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.Check CORBF's competition here
AVCRF vs EDTXF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, EDTXF has a market cap of 173.6M. Regarding current trading prices, AVCRF is priced at $0.07, while EDTXF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas EDTXF's P/E ratio is -10.12. In terms of profitability, AVCRF's ROE is -0.42%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, AVCRF is more volatile compared to EDTXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check EDTXF's competition here
AVCRF vs AMCY Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, AVCRF is priced at $0.07, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas AMCY's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to AMCY's ROE of N/A. Regarding short-term risk, AVCRF is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check AMCY's competition here
AVCRF vs NNGRF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, AVCRF is priced at $0.07, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, AVCRF's ROE is -0.42%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, AVCRF is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check NNGRF's competition here
AVCRF vs THOXF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, AVCRF is priced at $0.07, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas THOXF's P/E ratio is -14.40. In terms of profitability, AVCRF's ROE is -0.42%, compared to THOXF's ROE of -1.09%. Regarding short-term risk, AVCRF is more volatile compared to THOXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check THOXF's competition here
AVCRF vs DIUXF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, AVCRF is priced at $0.07, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, AVCRF's ROE is -0.42%, compared to DIUXF's ROE of -0.04%. Regarding short-term risk, AVCRF is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check DIUXF's competition here
AVCRF vs PFGTF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, PFGTF has a market cap of 80.1M. Regarding current trading prices, AVCRF is priced at $0.07, while PFGTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas PFGTF's P/E ratio is -4.93. In terms of profitability, AVCRF's ROE is -0.42%, compared to PFGTF's ROE of -0.86%. Regarding short-term risk, AVCRF is more volatile compared to PFGTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check PFGTF's competition here
AVCRF vs TIHE Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, AVCRF is priced at $0.07, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas TIHE's P/E ratio is 0.32. In terms of profitability, AVCRF's ROE is -0.42%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, AVCRF is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check TIHE's competition here
AVCRF vs BIOGF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, AVCRF is priced at $0.07, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, AVCRF's ROE is -0.42%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, AVCRF is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check BIOGF's competition here
AVCRF vs PCNEF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, AVCRF is priced at $0.07, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, AVCRF's ROE is -0.42%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, AVCRF is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check PCNEF's competition here
AVCRF vs LDXHF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, LDXHF has a market cap of 48.7M. Regarding current trading prices, AVCRF is priced at $0.07, while LDXHF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas LDXHF's P/E ratio is -6.50. In terms of profitability, AVCRF's ROE is -0.42%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, AVCRF is more volatile compared to LDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check LDXHF's competition here
AVCRF vs CLIFF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, AVCRF is priced at $0.07, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, AVCRF's ROE is -0.42%, compared to CLIFF's ROE of -0.10%. Regarding short-term risk, AVCRF is more volatile compared to CLIFF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check CLIFF's competition here
AVCRF vs SNANF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, SNANF has a market cap of 42.1M. Regarding current trading prices, AVCRF is priced at $0.07, while SNANF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas SNANF's P/E ratio is -19.05. In terms of profitability, AVCRF's ROE is -0.42%, compared to SNANF's ROE of -2.31%. Regarding short-term risk, AVCRF is more volatile compared to SNANF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check SNANF's competition here
AVCRF vs BIOQ Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, BIOQ has a market cap of 38.6M. Regarding current trading prices, AVCRF is priced at $0.07, while BIOQ trades at $43.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas BIOQ's P/E ratio is 15.82. In terms of profitability, AVCRF's ROE is -0.42%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, AVCRF is more volatile compared to BIOQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check BIOQ's competition here
AVCRF vs ANPCF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, ANPCF has a market cap of 34.2M. Regarding current trading prices, AVCRF is priced at $0.07, while ANPCF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas ANPCF's P/E ratio is -1.77. In terms of profitability, AVCRF's ROE is -0.42%, compared to ANPCF's ROE of -0.66%. Regarding short-term risk, AVCRF is more volatile compared to ANPCF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check ANPCF's competition here
AVCRF vs BMKDF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, BMKDF has a market cap of 26.4M. Regarding current trading prices, AVCRF is priced at $0.07, while BMKDF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas BMKDF's P/E ratio is -25.10. In terms of profitability, AVCRF's ROE is -0.42%, compared to BMKDF's ROE of +7.41%. Regarding short-term risk, AVCRF is more volatile compared to BMKDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check BMKDF's competition here
AVCRF vs ANPCY Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, ANPCY has a market cap of 24.3M. Regarding current trading prices, AVCRF is priced at $0.07, while ANPCY trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas ANPCY's P/E ratio is -1.18. In terms of profitability, AVCRF's ROE is -0.42%, compared to ANPCY's ROE of -0.66%. Regarding short-term risk, AVCRF is more volatile compared to ANPCY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check ANPCY's competition here
AVCRF vs IMMVF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, AVCRF is priced at $0.07, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, AVCRF's ROE is -0.42%, compared to IMMVF's ROE of -5.30%. Regarding short-term risk, AVCRF is more volatile compared to IMMVF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check IMMVF's competition here
AVCRF vs PCHM Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, PCHM has a market cap of 21.7M. Regarding current trading prices, AVCRF is priced at $0.07, while PCHM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas PCHM's P/E ratio is -0.02. In terms of profitability, AVCRF's ROE is -0.42%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, AVCRF is more volatile compared to PCHM. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check PCHM's competition here
AVCRF vs VILGF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, AVCRF is priced at $0.07, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas VILGF's P/E ratio is -0.30. In terms of profitability, AVCRF's ROE is -0.42%, compared to VILGF's ROE of N/A. Regarding short-term risk, AVCRF is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check VILGF's competition here
AVCRF vs VRCDF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, VRCDF has a market cap of 15.1M. Regarding current trading prices, AVCRF is priced at $0.07, while VRCDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas VRCDF's P/E ratio is -0.33. In terms of profitability, AVCRF's ROE is -0.42%, compared to VRCDF's ROE of -0.76%. Regarding short-term risk, AVCRF is more volatile compared to VRCDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check VRCDF's competition here
AVCRF vs IZOZF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, IZOZF has a market cap of 14.4M. Regarding current trading prices, AVCRF is priced at $0.07, while IZOZF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas IZOZF's P/E ratio is -7.92. In terms of profitability, AVCRF's ROE is -0.42%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, AVCRF is more volatile compared to IZOZF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check IZOZF's competition here
AVCRF vs ABDXF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, AVCRF is priced at $0.07, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, AVCRF's ROE is -0.42%, compared to ABDXF's ROE of -0.48%. Regarding short-term risk, AVCRF is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check ABDXF's competition here
AVCRF vs PMSNF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, PMSNF has a market cap of 11.8M. Regarding current trading prices, AVCRF is priced at $0.07, while PMSNF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas PMSNF's P/E ratio is -2.00. In terms of profitability, AVCRF's ROE is -0.42%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, AVCRF is more volatile compared to PMSNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check PMSNF's competition here
AVCRF vs MXDHF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, AVCRF is priced at $0.07, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, AVCRF's ROE is -0.42%, compared to MXDHF's ROE of -4.78%. Regarding short-term risk, AVCRF is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check MXDHF's competition here
AVCRF vs SQIDF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, AVCRF is priced at $0.07, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, AVCRF's ROE is -0.42%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, AVCRF is more volatile compared to SQIDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check SQIDF's competition here
AVCRF vs TDSGF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, TDSGF has a market cap of 5.9M. Regarding current trading prices, AVCRF is priced at $0.07, while TDSGF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas TDSGF's P/E ratio is -2.95. In terms of profitability, AVCRF's ROE is -0.42%, compared to TDSGF's ROE of -2.99%. Regarding short-term risk, AVCRF is more volatile compared to TDSGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check TDSGF's competition here
AVCRF vs RNVA Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, AVCRF is priced at $0.07, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas RNVA's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, AVCRF is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check RNVA's competition here
AVCRF vs IDXG Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, IDXG has a market cap of 3.8M. Regarding current trading prices, AVCRF is priced at $0.07, while IDXG trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas IDXG's P/E ratio is 3.04. In terms of profitability, AVCRF's ROE is -0.42%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, AVCRF is more volatile compared to IDXG. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check IDXG's competition here
AVCRF vs JMPHF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, JMPHF has a market cap of 3.6M. Regarding current trading prices, AVCRF is priced at $0.07, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, AVCRF's ROE is -0.42%, compared to JMPHF's ROE of +0.43%. Regarding short-term risk, AVCRF is more volatile compared to JMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check JMPHF's competition here
AVCRF vs IBXXF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, IBXXF has a market cap of 3M. Regarding current trading prices, AVCRF is priced at $0.07, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas IBXXF's P/E ratio is -0.50. In terms of profitability, AVCRF's ROE is -0.42%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, AVCRF is more volatile compared to IBXXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check IBXXF's competition here
AVCRF vs SLDX Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, SLDX has a market cap of 2.9M. Regarding current trading prices, AVCRF is priced at $0.07, while SLDX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas SLDX's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, AVCRF is more volatile compared to SLDX. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check SLDX's competition here
AVCRF vs SZLSF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, SZLSF has a market cap of 2.3M. Regarding current trading prices, AVCRF is priced at $0.07, while SZLSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas SZLSF's P/E ratio is -0.16. In terms of profitability, AVCRF's ROE is -0.42%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, AVCRF is more volatile compared to SZLSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check SZLSF's competition here
AVCRF vs IDTA Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, IDTA has a market cap of 2M. Regarding current trading prices, AVCRF is priced at $0.07, while IDTA trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas IDTA's P/E ratio is 4.88. In terms of profitability, AVCRF's ROE is -0.42%, compared to IDTA's ROE of +0.04%. Regarding short-term risk, AVCRF is more volatile compared to IDTA. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check IDTA's competition here
AVCRF vs ICBU Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, ICBU has a market cap of 1.9M. Regarding current trading prices, AVCRF is priced at $0.07, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas ICBU's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, AVCRF is more volatile compared to ICBU. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check ICBU's competition here
AVCRF vs IVRO Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, IVRO has a market cap of 1.7M. Regarding current trading prices, AVCRF is priced at $0.07, while IVRO trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas IVRO's P/E ratio is -0.77. In terms of profitability, AVCRF's ROE is -0.42%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, AVCRF is more volatile compared to IVRO. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check IVRO's competition here
AVCRF vs NSTM Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, NSTM has a market cap of 1.2M. Regarding current trading prices, AVCRF is priced at $0.07, while NSTM trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas NSTM's P/E ratio is -0.42. In terms of profitability, AVCRF's ROE is -0.42%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, AVCRF is more volatile compared to NSTM. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check NSTM's competition here
AVCRF vs DIGP Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, AVCRF is priced at $0.07, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas DIGP's P/E ratio is -1.04. In terms of profitability, AVCRF's ROE is -0.42%, compared to DIGP's ROE of +2.94%. Regarding short-term risk, AVCRF is more volatile compared to DIGP. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check DIGP's competition here
AVCRF vs EPGNF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, EPGNF has a market cap of 982.2K. Regarding current trading prices, AVCRF is priced at $0.07, while EPGNF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas EPGNF's P/E ratio is -0.05. In terms of profitability, AVCRF's ROE is -0.42%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, AVCRF is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check EPGNF's competition here
AVCRF vs SCRSF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, SCRSF has a market cap of 901.2K. Regarding current trading prices, AVCRF is priced at $0.07, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas SCRSF's P/E ratio is -0.30. In terms of profitability, AVCRF's ROE is -0.42%, compared to SCRSF's ROE of +1.97%. Regarding short-term risk, AVCRF is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check SCRSF's competition here
AVCRF vs RSHN Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, RSHN has a market cap of 817.5K. Regarding current trading prices, AVCRF is priced at $0.07, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas RSHN's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, AVCRF is more volatile compared to RSHN. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check RSHN's competition here
AVCRF vs MBGNF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, AVCRF is priced at $0.07, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, AVCRF's ROE is -0.42%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, AVCRF is more volatile compared to MBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check MBGNF's competition here
AVCRF vs NVTAQ Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, AVCRF is priced at $0.07, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, AVCRF's ROE is -0.42%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, AVCRF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.Check NVTAQ's competition here
AVCRF vs ARYC Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, AVCRF is priced at $0.07, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas ARYC's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, AVCRF is more volatile compared to ARYC. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check ARYC's competition here
AVCRF vs HCLC Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, AVCRF is priced at $0.07, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas HCLC's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, AVCRF is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check HCLC's competition here
AVCRF vs MEDVF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, AVCRF is priced at $0.07, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, AVCRF's ROE is -0.42%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, AVCRF is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check MEDVF's competition here
AVCRF vs CHHL Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, AVCRF is priced at $0.07, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas CHHL's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, AVCRF is more volatile compared to CHHL. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check CHHL's competition here
AVCRF vs IHTI Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, AVCRF is priced at $0.07, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas IHTI's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, AVCRF is more volatile compared to IHTI. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check IHTI's competition here
AVCRF vs MEDD Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, AVCRF is priced at $0.07, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas MEDD's P/E ratio is -0.01. In terms of profitability, AVCRF's ROE is -0.42%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, AVCRF is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check MEDD's competition here
AVCRF vs TOMDF Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, AVCRF is priced at $0.07, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas TOMDF's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, AVCRF is more volatile compared to TOMDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check TOMDF's competition here
AVCRF vs CGNH Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, AVCRF is priced at $0.07, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas CGNH's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, AVCRF is more volatile compared to CGNH. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check CGNH's competition here
AVCRF vs ABMC Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, AVCRF is priced at $0.07, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas ABMC's P/E ratio is 0.01. In terms of profitability, AVCRF's ROE is -0.42%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, AVCRF is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check ABMC's competition here
AVCRF vs RGDXQ Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, AVCRF is priced at $0.07, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, AVCRF is more volatile compared to RGDXQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check RGDXQ's competition here
AVCRF vs DMTKQ Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, AVCRF is priced at $0.07, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to DMTKQ's ROE of -1.06%. Regarding short-term risk, AVCRF is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check DMTKQ's competition here
AVCRF vs GWHP Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, AVCRF is priced at $0.07, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas GWHP's P/E ratio is -0.00. In terms of profitability, AVCRF's ROE is -0.42%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, AVCRF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.Check GWHP's competition here
AVCRF vs CYPS Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, CYPS has a market cap of 811. Regarding current trading prices, AVCRF is priced at $0.07, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas CYPS's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to CYPS's ROE of N/A. Regarding short-term risk, AVCRF is more volatile compared to CYPS. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check CYPS's competition here
AVCRF vs ROSGQ Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, AVCRF is priced at $0.07, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, AVCRF is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check ROSGQ's competition here
AVCRF vs BIOCQ Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, AVCRF is priced at $0.07, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas BIOCQ's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, AVCRF is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check BIOCQ's competition here
AVCRF vs HTGMQ Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, AVCRF is priced at $0.07, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, AVCRF is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check HTGMQ's competition here
AVCRF vs OPGX Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, OPGX has a market cap of 17. Regarding current trading prices, AVCRF is priced at $0.07, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas OPGX's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, AVCRF is more volatile compared to OPGX. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check OPGX's competition here
AVCRF vs MRPS Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, MRPS has a market cap of 0. Regarding current trading prices, AVCRF is priced at $0.07, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas MRPS's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to MRPS's ROE of N/A. Regarding short-term risk, AVCRF is more volatile compared to MRPS. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check MRPS's competition here
AVCRF vs BGNX Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, BGNX has a market cap of 0. Regarding current trading prices, AVCRF is priced at $0.07, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas BGNX's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to BGNX's ROE of N/A. Regarding short-term risk, AVCRF is more volatile compared to BGNX. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check BGNX's competition here
AVCRF vs EPGNY Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, AVCRF is priced at $0.07, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, AVCRF's ROE is -0.42%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, AVCRF is more volatile compared to EPGNY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check EPGNY's competition here
AVCRF vs AGHC Comparison August 2025
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 5.9M. In comparison, AGHC has a market cap of 0. Regarding current trading prices, AVCRF is priced at $0.07, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -5.79, whereas AGHC's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is -0.42%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, AVCRF is more volatile compared to AGHC. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.Check AGHC's competition here